These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 6132363)
41. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat. Gorzalka BB; Luck KA; Tanco SA Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168 [TBL] [Abstract][Full Text] [Related]
43. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats. Bhargava HN Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116 [TBL] [Abstract][Full Text] [Related]
44. Biogenic amines and control of melanophore stimulating hormone release. Bower A; Hadley ME; Hruby VJ Science; 1974 Apr; 184(4132):70-2. PubMed ID: 4544474 [TBL] [Abstract][Full Text] [Related]
45. Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG). Chiu P; Rajakumar G; Chiu S; Johnson RL; Mishra RK Peptides; 1985; 6(2):179-83. PubMed ID: 2863809 [TBL] [Abstract][Full Text] [Related]
46. Characterization of alpha-melanocyte-stimulating hormone (alpha-MSH)-like peptides in discrete regions of the rat brain. In vitro release of alpha-MSH from perifused hypothalamus and amygdala. Bunel DT; Delbende C; Blasquez C; Jegou S; Vaudry H Brain Res; 1990 Apr; 513(2):299-307. PubMed ID: 2161700 [TBL] [Abstract][Full Text] [Related]
47. Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings. Chiu S; Paulose CS; Mishra RK Peptides; 1981; 2(1):105-11. PubMed ID: 6113579 [TBL] [Abstract][Full Text] [Related]
48. Ion-induced release of LHRH, TRH and alpha-MSH from hypothalamic synaptosomes and its inhibition by vinblastine. Warberg J; Parker CR; Oliver C; Barnea A; Porter JC Pflugers Arch; 1980 May; 385(1):79-84. PubMed ID: 6774314 [No Abstract] [Full Text] [Related]
49. Effect of gonadectomy and reposition of gonadal steroids on alpha-melanocyte-stimulating hormone concentration in discrete hypothalamic areas during a 24-hour period. Scimonelli TN; Celis ME Neuroendocrinology; 1987 Jun; 45(6):441-5. PubMed ID: 3614548 [TBL] [Abstract][Full Text] [Related]
50. L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives. Rajakumar G; Singh AN; Naas F; Chiu S; Kwan CY; Johnson RL; Mishra RK J Hypertens Suppl; 1986 Dec; 4(5):S106-8. PubMed ID: 2883271 [TBL] [Abstract][Full Text] [Related]
51. alpha-MSH, MIF-I and melatonin: effects on novelty-induced defecation, plasma 11-OHCS and central catecholamines in rats. Datta PC; King MG Peptides; 1981; 2 Suppl 1():143-54. PubMed ID: 6115365 [TBL] [Abstract][Full Text] [Related]
52. Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats. Costain WJ; Buckley AT; Evans MC; Mishra RK; Johnson RL Peptides; 1999; 20(6):761-7. PubMed ID: 10477133 [TBL] [Abstract][Full Text] [Related]
53. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat. Kostrzewa RM; Saleh MI Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103 [TBL] [Abstract][Full Text] [Related]
54. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system. Yehuda S; Carasso RL Peptides; 1982; 3(2):105-10. PubMed ID: 6124951 [TBL] [Abstract][Full Text] [Related]
55. Selective effects of alpha-MSH and MIF-1 on the blood-brain barrier. Sankar R; Domer FR; Kastin AJ Peptides; 1981; 2(3):345-7. PubMed ID: 6117842 [TBL] [Abstract][Full Text] [Related]
56. Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia. Sharma S; Paladino P; Gabriele J; Saeedi H; Henry P; Chang M; Mishra RK; Johnson RL Peptides; 2003 Feb; 24(2):313-9. PubMed ID: 12668218 [TBL] [Abstract][Full Text] [Related]
57. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Dhillo WS; Small CJ; Seal LJ; Kim MS; Stanley SA; Murphy KG; Ghatei MA; Bloom SR Neuroendocrinology; 2002 Apr; 75(4):209-16. PubMed ID: 11979051 [TBL] [Abstract][Full Text] [Related]
58. Ion and ion channel involvement in alpha-melanocyte-stimulating hormone secretion from superfused slices of rat hypothalamus. Tiligada E; Wilson JF Neurosci Lett; 1988 Dec; 95(1-3):318-22. PubMed ID: 2852321 [TBL] [Abstract][Full Text] [Related]
59. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN. Johnson RL; Rajakumar G; Yu KL; Mishra RK J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104 [TBL] [Abstract][Full Text] [Related]
60. Coexistence of immunoreactivity for melanin-concentrating hormone and alpha-melanocyte-stimulating hormone in the hypothalamus of the rat. Naito N; Kawazoe I; Nakai Y; Kawauchi H; Hirano T Neurosci Lett; 1986 Sep; 70(1):81-5. PubMed ID: 3534639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]